Mikhail Spartakovich Arbatsky

The paper considers the state of the regenerative medicine market. The purpose of the work is to review the existing sources on the economic issues of regenerative medicine products and their introduction to the market. Due to the fact that the market for regenerative medicine is in growth stage, the number of sources is extremely limited. The review collected, analyzed and systematized data on the volume and dynamics of the market, its financing, drivers and barriers, provides a list of regulatory documents regulating the market, government support measures and opportunities for start-up entrepreneurs. The performed research characterizes the market of regenerative medicine products as a market with strong potential for growth in the next decade. The results obtained helped to identify problematic aspects of the market that require examine issues by specialized specialists. Subject to consideration of negative reviews of the federal law No. 180-FZ “On biomedical cell products” adopted on June 23, 2016, continued active state support and legal regulation, products and services of the regenerative medicine market will be able to win their niche and compete with current drugs and methods of treatment.